Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
58
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
32
users have liked this narrative
6
users have commented on this narrative
89
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Orbia Advance Corporation. de
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Urbanization, Water Scarcity And Digitalization Will Transform Infrastructure
Key Takeaways Faster-than-expected restructuring, investment, and cost reductions set up Orbia for improved profitability and accelerated revenue growth. Growth in fiber, electrification, and agricultural solutions positions Orbia to benefit structurally from long-term global infrastructure and sustainability trends.
View narrative
Mex$57.72
FV
78.8% undervalued
intrinsic discount
6.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Talos Energy
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
US Gulf Coast Expansion Will Boost Carbon Capture Despite Risks
Key Takeaways CEO-driven operational efficiency and a strong culture are set to structurally enhance margins and drive superior earnings growth beyond what analysts currently expect. Strategic flexibility, robust assets, and leadership in decarbonization position the company for above-market growth and diversified future revenue streams.
View narrative
US$19.38
FV
59.5% undervalued
intrinsic discount
-2.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
MAHLE Metal Leve
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Latin American Demand And Emissions Rules Will Drive Advanced Systems
Key Takeaways Accelerated vehicle electrification and green mobility initiatives in Latin America position MAHLE Metal Leve for strong, above-market revenue and earnings growth driven by demand tailwinds. Rapid synergy realization from acquisitions, cost discipline, and a diversified, resilient aftermarket business are set to boost margins, stabilize earnings, and enhance valuation quality.
View narrative
R$39.00
FV
28.6% undervalued
intrinsic discount
7.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Pharma Mar
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Marine-derived Oncology Will Benefit From Demographic Shifts
Key Takeaways Expanded indications for ZEPZELCA and rapid international rollout could make PharmaMar a dominant player in underserved oncology markets with significantly increased recurring revenues. A strong pipeline, ample cash, and shifting demographics support future growth through new approvals, strategic deals, and rising demand for targeted cancer therapies.
View narrative
€118.00
FV
33.0% undervalued
intrinsic discount
65.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
16 days ago
author updated this narrative
Afry
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Energy Transition, Urbanization And Digitalization Will Expand Orders
Key Takeaways Strategic positioning in energy transition and digital services, supported by acquisitions and expertise, drives strong growth prospects across diverse high-margin sectors and geographies. Ongoing operational restructuring and focus on high-value, long-term contracts are likely to yield greater-than-expected margin improvement and recurring revenue stability.
View narrative
SEK 240.00
FV
37.3% undervalued
intrinsic discount
4.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Lojas Renner
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Brazil's Rising Middle Class And Digital Adoption Will Boost Retail
Key Takeaways Fully integrated digital, distribution, and in-house financial platforms position the company for outperformance in market share, earnings quality, and margin expansion versus industry peers. Growth from private labels, trusted brand, and urban market expansion will drive long-term revenue and profitability gains as cost leverage amplifies bottom-line results.
View narrative
R$23.95
FV
24.7% undervalued
intrinsic discount
10.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Genus
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Gene-Edited Livestock Solutions Will Capture Expanding Protein Demand
Key Takeaways Rapid commercialization of new products and major customer wins position Genus for accelerated revenue and margin growth above current market expectations. Strong R&D, regulatory progress, and cash generation support premium pricing, market share gains, and sustained investments that enhance long-term profitability and resilience.
View narrative
UK£32.00
FV
21.3% undervalued
intrinsic discount
6.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Fevertree Drinks
AN
AnalystHighTarget
Consensus Narrative from 16 Analysts
Secular Cocktail Culture And US Partnership Will Spur Demand
Key Takeaways Transformational partnerships and global expansion could drive much higher growth, margin resilience, and earnings quality than currently anticipated in both core and emerging markets. Strong positioning in health-conscious and premium segments enables price leadership, brand loyalty, and robust long-term demand across diverse geographies.
View narrative
UK£13.26
FV
28.6% undervalued
intrinsic discount
10.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
ZhongAn Online P & C Insurance
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
China's Digital Adoption And AI Will Transform Insurtech Landscape
Key Takeaways Proprietary AI and tech-driven automation are driving underwriting profitability, lowering expenses, and supporting faster, sustained margin expansion. Rapid digital channel adoption, product innovation, and international B2B growth underpin structurally higher recurring revenues and strong diversification potential.
View narrative
HK$25.05
FV
28.5% undervalued
intrinsic discount
14.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
16 days ago
author updated this narrative
Value any company in seconds
Popular companies